Related Experiment Video

Updated: Nov 6, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.8K

Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular risk

Vivencio Barrios1, Carlos Escobar2

  • 1Cardiology Department, University Hospital Ramón Y Cajal. Alcalá University, Madrid, Spain.

Expert Review of Clinical Pharmacology
|May 10, 2021
PubMed

Insights

Combining rosuvastatin and ezetimibe effectively lowers low-density lipoprotein cholesterol (LDL-C) in patients with hypercholesterolemia. This combination therapy offers significant LDL-C reductions and a favorable safety profile for cardiovascular disease prevention.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Lipid-lowering therapies, particularly statins, are crucial for reducing cardiovascular events by lowering low-density lipoprotein cholesterol (LDL-C).
  • Many patients struggle to reach target LDL-C levels with high-intensity statins alone, necessitating alternative or combination strategies.

Purpose of the Study:

  • To review the current evidence on the efficacy and safety of combining rosuvastatin and ezetimibe for dyslipidemia management.
  • To highlight the complementary mechanisms and benefits of this combination therapy in achieving LDL-C reduction.

Main Methods:

  • A systematic literature search was performed using PubMed (MEDLINE).
  • Keywords included Rosuvastatin, Ezetimibe, Dyslipidemia, and treatment.
  • Original clinical trial data, prospective/retrospective studies, and reviews were selected for analysis.

Main Results:

  • The combination of rosuvastatin (10-40 mg) and ezetimibe (10 mg) achieves substantial LDL-C reductions, ranging from 60% to 75%.
  • This combination demonstrates a good safety profile across a wide spectrum of hypercholesterolemia patients, including high-risk individuals.
  • Fixed-dose combination may improve patient adherence to medication regimens.

Conclusions:

  • Rosuvastatin and ezetimibe combination therapy is a potent strategy for managing dyslipidemia and achieving significant LDL-C reduction.
  • The combination offers a favorable safety profile and potential for improved adherence, supporting its role in cardiovascular disease prevention.

Keywords:
Cholesterolcombined therapyezetimiberosuvastatin

More Related Videos

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay08:18

High-throughput Nitrobenzoxadiazole-labeled Cholesterol Efflux Assay

Published on: January 7, 2019

9.3K
Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

1.3K

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
89
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
91
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
441
Dosage Regimen: Fixed Dose01:01

Dosage Regimen: Fixed Dose

Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.6K